The intent of the FY20 CPMRP TRA is to support translational research that will accelerate the movement of evidence-based ideas in chronic pain management research into clinical applications, such as healthcare products, technologies, clinical practice guidelines, and/or models of care.

TRA

credit:

applications should explain how the proposed work will inform the development, refinement, and/or revision of existing standards of care, recommendations, or guidelines for managing chronic pain.

Studies evaluating opioid-based therapeutic interventions are not allowed.